EViTRADE Appoints Investor Relations Firm – Updated
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Inactive and sedentary lifestyles have been consistently linked to both...
Berlin – From 17 to 21 June 2019, the International Federation of Societies for Surgery of the Hand (IFSSH) and...
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 4, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX & MDAX; Nasdaq:...
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 4, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
RESEARCH TRIANGLE PARK, NC and NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Adhera Therapeutics (OTCQB: ATRX), a...
VANCOUVER, BC / ACCESSWIRE / March 4, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
AUSTIN, TX / ACCESSWIRE / March 4, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, announced today...
Innovative XCART platform with demonstrated proof of mechanism and preclinical evidence of target specificity positions Xenetic to address high value...
TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"),...
TORONTO, ONTRAIO / ACCESSWIRE / March 4, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
The Company qualifies for reduced or waived fees for medical device submissions with the FDA HOUSTON, TX / ACCESSWIRE /...